Pacific Global Investment Management CO Pfizer Inc Transaction History

Pacific Global Investment Management CO

$529 Million
Q3 2024

A detailed history of Pacific Global Investment Management CO transactions in Pfizer Inc stock. As of the latest transaction made, Pacific Global Investment Management CO holds 25,681 shares of PFE stock, worth $663,340. This represents 0.14% of its overall portfolio holdings.

Number of Shares

25,681

Previous 27,765 7.51%

Holding current value

$663,340

Previous $776,000 4.25%

% of portfolio

0.14%

Previous 0.15%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$27.7 - $31.39 $57,726 - $65,416	-2,084 Reduced 7.51%	25,681 $743,000
Q2 2024 Aug 09, 2024	SELL	$25.26 - $29.6 $158,102 - $185,266	-6,259 Reduced 18.4%	27,765 $776,000
Q1 2024 May 10, 2024	SELL	$25.89 - $29.73 $277,126 - $318,229	-10,704 Reduced 23.93%	34,024 $944,000
Q4 2023 Feb 08, 2024	SELL	$26.13 - $33.94 $184,608 - $239,786	-7,065 Reduced 13.64%	44,728 $1.29 Million
Q3 2023 Nov 14, 2023	SELL	$32.09 - $37.51 $54,264 - $63,429	-1,691 Reduced 3.16%	51,793 $1.72 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $56,094 - $64,899	1,553 Added 2.99%	53,484 $1.96 Million
Q1 2023 Apr 28, 2023	BUY	$39.39 - $51.28 $7,129 - $9,281	181 Added 0.35%	51,931 $2.12 Million
Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $5,594 - $7,303	134 Added 0.26%	51,750 $2.65 Million
Q3 2022 Nov 01, 2022	BUY	$43.76 - $53.42 $39,821 - $48,612	910 Added 1.79%	51,616 $2.26 Million
Q2 2022 Aug 05, 2022	SELL	$46.53 - $55.17 $32,198 - $38,177	-692 Reduced 1.35%	50,706 $2.66 Million
Q1 2022 Apr 25, 2022	SELL	$45.75 - $56.69 $31,659 - $39,229	-692 Reduced 1.33%	51,398 $2.66 Million
Q4 2021 Feb 03, 2022	BUY	$41.32 - $61.25 $4,090 - $6,063	99 Added 0.19%	52,090 $3.08 Million
Q3 2021 Nov 04, 2021	SELL	$39.25 - $50.42 $95,142 - $122,218	-2,424 Reduced 4.45%	51,991 $2.24 Million
Q2 2021 Aug 13, 2021	SELL	$35.91 - $40.68 $75,446 - $85,468	-2,101 Reduced 3.72%	54,415 $2.13 Million
Q1 2021 May 13, 2021	SELL	$33.49 - $37.77 $176,927 - $199,538	-5,283 Reduced 8.55%	56,516 $2.05 Million
Q4 2020 Feb 12, 2021	BUY	$33.47 - $42.56 $313,212 - $398,276	9,358 Added 17.84%	61,799 $2.28 Million
Q3 2020 Nov 13, 2020	BUY	$31.75 - $37.25 $124,714 - $146,318	3,928 Added 8.1%	52,441 $1.93 Million
Q2 2020 Aug 14, 2020	SELL	$30.12 - $36.54 $113,672 - $137,901	-3,774 Reduced 7.22%	48,513 $1.59 Million
Q1 2020 May 15, 2020	SELL	$27.03 - $38.62 $242,540 - $346,537	-8,973 Reduced 14.65%	52,287 $1.71 Million
Q4 2019 Feb 14, 2020	SELL	$32.92 - $37.36 $18,402 - $20,884	-559 Reduced 0.9%	61,260 $2.4 Million
Q3 2019 Nov 14, 2019	BUY	$32.49 - $42.13 $148,479 - $192,534	4,570 Added 7.98%	61,819 $2.22 Million
Q2 2019 Aug 14, 2019	SELL	$36.98 - $41.52 $91,969 - $103,260	-2,487 Reduced 4.16%	57,249 $2.48 Million
Q1 2019 May 14, 2019	SELL	$37.5 - $41.2 $3,862 - $4,243	-103 Reduced 0.17%	59,736 $2.54 Million
Q4 2018 Feb 14, 2019	SELL	$38.47 - $43.86 $12,425 - $14,166	-323 Reduced 0.54%	59,839 $2.61 Million
Q3 2018 Nov 14, 2018	SELL	$34.47 - $41.81 $8,789 - $10,661	-255 Reduced 0.42%	60,162 $2.65 Million
Q2 2018 Aug 14, 2018	SELL	$32.98 - $35.16 $32,947 - $35,124	-999 Reduced 1.63%	60,417 $2.19 Million
Q1 2018 May 15, 2018	BUY	$31.91 - $37.02 $3,095 - $3,590	97 Added 0.16%	61,416 $2.18 Million
Q4 2017 Feb 14, 2018	SELL	$33.26 - $35.29 $93,493 - $99,200	-2,811 Reduced 4.38%	61,319 $2.22 Million
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $12,028 - $13,250	388 Added 0.61%	64,130 $2.29 Million
Q2 2017 Aug 14, 2017	BUY	N/A	63,742	63,742 $2.14 Million

Others Institutions Holding PFE

# of Institutions

3,258

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $145B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacific Global Investment Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Pacific Global Investment Management CO with notifications on news.

Account

Pacific Global Investment Management CO Pfizer Inc Transaction History